ProMIS Neurosciences (PMN) Stock Forecast & Price Target

$1.60

-0.42 (-20.79%)

(As of 07/26/2024 ET)

ProMIS Neurosciences - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 1 Analyst Ratings

Based on 1 Wall Street analysts who have issued ratings for ProMIS Neurosciences in the last 12 months, the stock has a consensus rating of "Buy." Out of the 1 analysts, 1 has given a buy rating for PMN.

Consensus Price Target

$8.00
400.00% Upside

High Forecast	$8.00
Average Forecast	$8.00
Low Forecast	$8.00

According to the 1 analysts' twelve-month price targets for ProMIS Neurosciences, the average price target is $8.00. The highest price target for PMN is $8.00, while the lowest price target for PMN is $8.00. The average price target represents a forecasted upside of 400.00% from the current price of $1.60.

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Buy	Buy	Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)	1 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$8.00	$8.00	$8.00	N/A
Forecasted Upside	400.00% Upside	316.67% Upside	316.67% Upside	N/A

Get ProMIS Neurosciences Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for PMN and its competitors with MarketBeat's FREE daily newsletter.

Ad MarketBeat

We just added a $300 account credit to your MarketBeat subscription

MarketBeat All Access is our complete suite of portfolio monitoring software, research tools, stock screeners, proprietary reports, and more. Upgrade today and get $300 off your 2024-2025 subscription. Free for 30 days.

Start Your Risk-Free Trial Here

PMN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

PMN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

ProMIS Neurosciences Stock vs. The Competition

Type	ProMIS Neurosciences	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.72	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	400.00% Upside	3,123.18% Upside	9.15% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
10/2/2023	BTIG Research 2 of 5 stars		Initiated Coverage	Buy	$8.00	+316.67%
7/17/2023	Leede Jones Gab 3 of 5 stars	D. Loe Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Speculative Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 07:11 AM ET.

PMN Forecast - Frequently Asked Questions

What is ProMIS Neurosciences' forecast for 2024?: According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for ProMIS Neurosciences is $8.00, with a high forecast of $8.00 and a low forecast of $8.00.
Should I buy or sell ProMIS Neurosciences stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ProMIS Neurosciences in the last year. There is currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" PMN shares.
Does ProMIS Neurosciences's stock price have much upside?: According to analysts, ProMIS Neurosciences's stock has a predicted upside of 316.67% based on their 12-month stock forecasts.
Do Wall Street analysts like ProMIS Neurosciences more than its competitors?: Analysts like ProMIS Neurosciences more than other "medical" companies. The consensus rating for ProMIS Neurosciences is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how PMN compares to other companies.